미국의 유방 MRI 시장 규모, 점유율, 동향 분석 : 제품별, 촬상 기술/조영 용도별, 상태별, 최종 용도별, 부문별 예측(2025-2033년)
U.S. Breast MRI Market Size, Share & Trends Analysis By Product (Systems, Coils, Software), By Imaging Technique/Contrast Use (CE-MRI, Ab-MRI), By Condition (Malignant, Benign), By End-use, And Segment Forecasts, 2025 - 2033
상품코드:1790421
리서치사:Grand View Research, Inc.
발행일:2025년 07월
페이지 정보:영문 110 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
미국의 유방 MRI 시장 요약
미국의 유방 MRI 시장 규모는 2024년에 7억 9,361만 달러로 평가되었습니다. 2033년에는 18억 7,880만 달러에 달하고, 2025-2033년 10.05%의 연평균 복합 성장률(CAGR)을 보일 것으로 예측됩니다. 미국 내 유방 MRI 수요는 유방암 유병률 증가와 의료용 영상처리에 대한 수요 증가, 임상시험 증가 및 자기공명영상 기술의 지속적인 발전으로 인해 증가하고 있습니다.
유방암 및 기타 유방 관련 질환의 유병률 증가는 시장 확대를 크게 촉진할 것으로 예측됩니다. National Breast Cancer Foundation, Inc.가 2025년 6월에 발표한 자료에 따르면, 미국 여성 8명 중 1명이 평생 동안 유방암 진단을 받을 것이라고 합니다. 또한, 국제암연구소의 예측에 따르면, 2022년부터 2050년 사이에 미국 내 유방암 발병률이 27.8% 증가하여 2050년에는 약 350,693명의 환자가 발생할 것으로 예상하고 있습니다. 이러한 암 발병률의 큰 폭 증가는 국가 전체에서 유방 자기공명영상에 대한 수요를 촉진할 것으로 예측됩니다.
또한, 암 검출을 위한 첨단 자기공명영상법을 평가하고 혁신적인 영상 솔루션을 개발하기 위한 임상시험 증가는 시장 성장에 크게 기여할 것으로 예측됩니다. 이러한 임상시험은 진단 정확도 향상, 조기 발견 강화, 신기술 검증에 있어 매우 중요합니다.
목차
제1장 조사 방법과 범위
제2장 주요 요약
제3장 미국의 유방 MRI 시장 변수, 동향, 범위
시장 계통 전망
상위 시장 전망
시장 역학
시장 성장 촉진요인 분석
시장 성장 억제요인 분석
시장 기회 분석
시장이 해결해야 할 과제 분석
미국의 유방 MRI 시장 분석 툴
업계 분석 - Porter의 Five Forces 분석
PESTEL 분석
제4장 미국의 유방 MRI 시장 : 제품 추정·동향 분석
부문 대시보드
미국의 유방 MRI 시장 제품 변동 분석
미국의 유방 MRI 시장 규모와 동향 분석(제품별, 2021-2033년)
시스템
코일
소프트웨어
제5장 미국의 유방 MRI 시장 : 영상 기술/조영용도 추정·동향 분석
부문 대시보드
미국의 유방 MRI 시장 영상 기술/조영용도 변동 분석
미국의 유방 MRI 시장 규모와 동향 분석(영상 기술별/조영 용도별, 2021-2033년)
조영MRI(CE-MRI)
비조영/단축 유방 MRI(Ab-MRI)
제6장 미국의 유방 MRI 시장 : 상태 추정·동향 분석
부문 대시보드
미국의 유방 MRI 시장 상황 변동 분석
미국의 유방 MRI 시장 규모와 동향 분석(상태별, 2021-2033년)
양성
악성
제7장 미국의 유방 MRI 장비 : 최종 용도 추정·동향 분석
부문 대시보드
미국의 유방 MRI 시장 최종 용도 변동 분석
미국의 유방 MRI 시장 규모와 동향 분석(최종 용도별, 2021-2033년)
병원 및 진료소
진단 영상 센터
유방암 케어 센터
학술연구기관
기타
제8장 경쟁 구도
주요 시장 진출기업의 최근 동향과 영향 분석
기업/경쟁 분류
Innovators
벤더 구도
주요 유통업체 및 채널 파트너 리스트
Key customers
US key company market share analysis, 2024
GE HealthCare
Siemens Medical Solutions USA, Inc.
Koninklijke Philips NV
Canon Medical Systems
Fujifilm Healthcare
United Imaging Healthcare Co., Ltd.
AURORA HEALTHCARE US CORP
QED(Quality Electrodynamics)
MR Instruments, Inc.
iCAD Inc.
Subtle Medical, Inc.
Arterys(Tempus)
히트맵 분석/기업 시장 현황 분석
2024년 기업의 시장 점유율 예측 분석
기타 주요 시장 기업 리스트
LSH
영문 목차
영문목차
U.S. Breast MRI Market Summary
The U.S. breast MRI market size was estimated at USD 793.61 million in 2024 and is projected to reach USD 1,878.8 million by 2033, growing at a CAGR of 10.05% from 2025 to 2033. The demand for breast MRI in the U.S. is increasing due to the rising prevalence of breast cancer and the growing demand for medical imaging, along with growing clinical trials and continuous technological advancements in magnetic resonance imaging.
The growing prevalence of breast cancer and other breast-related abnormalities is expected to drive market expansion significantly. According to data published by the National Breast Cancer Foundation, Inc. in June 2025, approximately 1 in 8 women in the U.S. will be diagnosed with breast cancer during their lifetime. In addition, projections from the International Agency for Research on Cancer estimate a 27.8% increase in breast cancer incidence in the U.S. between 2022 and 2050, with cases expected to reach approximately 350,693 by 2050. This substantial rise in cancer cases is anticipated to fuel the demand for breast magnetic resonance imaging procedures across the country.
Furthermore, the increasing number of clinical trials evaluating advanced magnetic resonance imaging modalities for cancer detection and developing innovative imaging solutions is expected to contribute significantly to market growth. These trials are crucial in improving diagnostic accuracy, enhancing early detection, and validating new technologies.
U.S. Breast MRI Market Report Segmentation
This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. breast MRI market report based on product, imaging technique/contrast use, condition, and end-use:
Product Outlook (Revenue, USD Million, 2021 - 2033)
Systems
By MRI System Type
Closed MRI Systems
Open MRI Systems
By Field Strength
1.5 Tesla (1.5T)
3 Tesla (3T)
7 Tesla (7T)
By Dimensional Modality
3D Breast MRI
4D Breast MRI
Coils
By Coil Configuration
Unilateral Breast Coils
Bilateral Breast Coils
By Channel Count
8-Channel Breast Coils
16-Channel (or Higher) Breast Coils
By Functionality
Diagnostic-Only Coils
Biopsy-Compatible Breast Coils
Software
Imaging Technique / Contrast Use Outlook (Revenue, USD Million, 2021 - 2033)
Contrast-Enhanced MRI (CE-MRI)
Non-Contrast / Abbreviated Breast MRI (Ab-MRI)
Condition Outlook (Revenue, USD Million, 2021 - 2033)
Malignant
Benign
End-use Outlook (Revenue, USD Million, 2021 - 2033)
Hospitals and Clinics
Diagnostic Imaging Centers
Breast Care Centers
Academic & Research Institutes
Others
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Imaging Technique/Contrast Use
1.1.3. Condition
1.1.4. End use
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR's internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. U.S. Breast MRI Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing burden of breast cancer
3.2.1.2. Rising awareness about early diagnosis
3.2.1.3. Favorable government initiatives
3.2.2. Market restraint analysis
3.2.2.1. Alternative approaches for breast cancer management
3.2.3. Market opportunity analysis
3.2.3.1. Rising number of clinical trials
3.2.3.2. Increasing funding and investments
3.2.3.3. Advancements in technology
3.2.4. Market challenge analysis
3.2.4.1. Shortage of radiologists
3.3. U.S. Breast MRI Market Analysis Tools
3.3.1. Industry Analysis - Porter's
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political & Legal Landscape
3.3.2.2. Economic and Social Landscape
3.3.2.3. Technological landscape
Chapter 4. U.S. Breast MRI Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. U.S. Breast MRI Market Product Movement Analysis
4.3. U.S. Breast MRI Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
4.4. Systems
4.4.1. Systems market estimates and forecasts for 2021 - 2033 (USD Million)
4.4.1.1. By MRI System Type
4.4.1.1.1. Closed MRI Systems
4.4.1.1.1.1. Closed MRI systems market estimates and forecasts for 2021 - 2033 (USD Million)
4.4.1.1.2. Open MRI Systems
4.4.1.1.2.1. Open MRI systems market estimates and forecasts for 2021 - 2033 (USD Million)
4.4.1.2. By Field Strength
4.4.1.2.1. 1.5 Tesla (1.5T)
4.4.1.2.1.1. 1.5 Tesla (1.5T) market estimates and forecasts for 2021 - 2033 (USD Million)
4.4.1.2.2. 3 Tesla (3T)
4.4.1.2.2.1. 3 Tesla (3T) market estimates and forecasts for 2021 - 2033 (USD Million)
4.4.1.2.3. 7 Tesla (7T)
4.4.1.2.3.1. 7 Tesla (7T) market estimates and forecasts for 2021 - 2033 (USD Million)
4.4.1.3. By Dimensional Modality
4.4.1.3.1. 3D Breast MRI
4.4.1.3.1.1. 3D breast MRI market estimates and forecasts for 2021 - 2033 (USD Million)
4.4.1.3.2. 4D Breast MRI
4.4.1.3.2.1. 4D breast MRI market estimates and forecasts for 2021 - 2033 (USD Million)
4.5. Coils
4.5.1. Coils market estimates and forecasts for 2021 - 2033 (USD Million)
4.5.1.1. By Coil Configuration
4.5.1.1.1. Unilateral Breast Coils
4.5.1.1.1.1. Unilateral breast coils market estimates and forecasts for 2021 - 2033 (USD Million)
4.5.1.1.2. Bilateral Breast Coils
4.5.1.1.2.1. Bilateral breast coils market estimates and forecasts for 2021 - 2033 (USD Million)
4.5.1.2. By Channel Count
4.5.1.2.1. 8-Channel Breast Coils
4.5.1.2.1.1. 8-channel breast coils market estimates and forecasts for 2021 - 2033 (USD Million)
4.5.1.2.2. 16-Channel Breast Coils
4.5.1.2.2.1. 16-channel breast coils market estimates and forecasts for 2021 - 2033 (USD Million)
4.5.1.3. By Functionality
4.5.1.3.1. Diagnostic-Only Coils
4.5.1.3.1.1. Diagnostic-only coils market estimates and forecasts for 2021 - 2033 (USD Million)
4.5.1.3.2. Biopsy-Compatible Breast Coils
4.5.1.3.2.1. Biopsy-compatible breast coils market estimates and forecasts for 2021 - 2033 (USD Million)
4.6. Software
4.6.1. Software market estimates and forecasts for 2021 - 2033 (USD Million)
Chapter 5. U.S. Breast MRI Market: Imaging Technique / Contrast Use Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. U.S. Breast MRI Market Imaging Technique / Contrast Use Movement Analysis
5.3. U.S. Breast MRI Market Size & Trend Analysis, by Imaging Technique / Contrast Use, 2021 to 2033 (USD Million)
5.4. Contrast-Enhanced MRI (CE-MRI)
5.4.1. Contrast-Enhanced MRI (CE-MRI) market estimates and forecasts for 2021 - 2033 (USD Million)
5.5. Non-Contrast / Abbreviated Breast MRI (Ab-MRI)
5.5.1. Non-Contrast / Abbreviated Breast MRI (Ab-MRI) market estimates and forecasts for 2021 - 2033 (USD Million)
Chapter 6. U.S. Breast MRI Market: Condition Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. U.S. Breast MRI Market Condition Movement Analysis
6.3. U.S. Breast MRI Market Size & Trend Analysis, by Condition, 2021 to 2033 (USD Million)
6.4. Benign
6.4.1. Benign market estimates and forecasts for 2021 - 2033 (USD Million)
6.5. Malignant
6.5.1. Malignant market estimates and forecasts for 2021 - 2033 (USD Million)
Chapter 7. U.S. Breast MRI Devices: End Use Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. U.S. Breast MRI Market End Use Movement Analysis
7.3. U.S. Breast MRI Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
7.4. Hospitals and Clinics
7.4.1. Hospitals and clinics market estimates and forecasts for 2021 - 2033 (USD Million)
7.5. Diagnostic Imaging Centers
7.5.1. Diagnostic imaging centers market estimates and forecasts for 2021 - 2033 (USD Million)
7.6. Breast Care Centers
7.6.1. Breast care centers market estimates and forecasts for 2021 - 2033 (USD Million)
7.7. Academic & Research Institutes
7.7.1. Academic & research institutes market estimates and forecasts for 2021 - 2033 (USD Million)
7.8. Others
7.8.1. Others market estimates and forecasts for 2021 - 2033 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.2.1. Innovators
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. U.S. key company market share analysis, 2024
8.3.4. GE HealthCare
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Product benchmarking
8.3.4.4. Strategic initiatives
8.3.5. Siemens Medical Solutions USA, Inc.
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Product benchmarking
8.3.5.4. Strategic initiatives
8.3.6. Koninklijke Philips N.V.
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Product benchmarking
8.3.6.4. Strategic initiatives
8.3.7. Canon Medical Systems
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Product benchmarking
8.3.7.4. Strategic initiatives
8.3.8. Fujifilm Healthcare
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Product benchmarking
8.3.8.4. Strategic initiatives
8.3.9. United Imaging Healthcare Co., Ltd.
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Product benchmarking
8.3.9.4. Strategic initiatives
8.3.10. AURORA HEALTHCARE US CORP
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Product benchmarking
8.3.10.4. Strategic initiatives
8.3.11. QED (Quality Electrodynamics)
8.3.11.1. Company overview
8.3.11.2. Financial performance
8.3.11.3. Product benchmarking
8.3.11.4. Strategic initiatives
8.3.12. MR Instruments, Inc.
8.3.12.1. Company overview
8.3.12.2. Financial performance
8.3.12.3. Product benchmarking
8.3.12.4. Strategic initiatives
8.3.13. iCAD Inc.
8.3.13.1. Company overview
8.3.13.2. Financial performance
8.3.13.3. Product benchmarking
8.3.13.4. Strategic initiatives
8.3.14. Subtle Medical, Inc.
8.3.14.1. Company overview
8.3.14.2. Financial performance
8.3.14.3. Product benchmarking
8.3.14.4. Strategic initiatives
8.3.15. Arterys (Tempus)
8.3.15.1. Company overview
8.3.15.2. Financial performance
8.3.15.3. Product benchmarking
8.3.15.4. Strategic initiatives
8.4. Heat Map Analysis/ Company Market Position Analysis
8.5. Estimated Company Market Share Analysis, 2024
